Liu, D., Gong, J., Li, B., Yao, J., Li, W., Liu, F., Xie, L., Qin, Y., Zhang, Y., Li, Z., Yang, J., Xing, S., Wu, H., Shen, L. (2026). A first-in-human phase I/II study evaluating CTS3497, an MTA-cooperative PRMT5 inhibitor, in advanced or metastatic
                    <i>MTAP</i>
                    -deficient solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3115